Transactions on Additive Manufacturing Meets Medicine
Vol. 2 No. 1 (2020): Trans. AMMM

PEGDA drug delivery scaffolds manufactured with a novel hybrid AM process

Main Article Content

Natalia Rekowska , Jan Konasch , Alexander Reiss , Robert Mau , Thomas Eickner , Hermann Seitz , Niels Grabow , Michael Teske 

Copyright (c) 2020 AMMM

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Additive manufacturing (AM) of drug delivery systems (DDS) is a promising tool for the development of patient-tailored treatments to ensure exact formation of individual scaffolds with specific incorporated drug combinations and concentrations. This study describes a novel hybrid AM process, combining stereolithography and inkjet printing, for printing a basic Polyethylene Glycol Diacrylate (PEGDA) DDS body and placing the model drug acetylsalicylic acid (ASA) in different drug depot locations. Adjusting the drug release by drug depot positioning according to drug diffusion is being investigated. The drug release rates from first 3D printed samples are being shown. 

Article Details

How to Cite

PEGDA drug delivery scaffolds manufactured with a novel hybrid AM process. (2020). Transactions on Additive Manufacturing Meets Medicine, 2(1). https://doi.org/10.18416/AMMM.2020.2009021

References

How to Cite

PEGDA drug delivery scaffolds manufactured with a novel hybrid AM process. (2020). Transactions on Additive Manufacturing Meets Medicine, 2(1). https://doi.org/10.18416/AMMM.2020.2009021

Most read articles by the same author(s)

<< < 1 2 3 > >>